This bill changes prior authorization rules for health insurance plans to improve access to ongoing treatments. It requires that prior authorizations for chronic conditions or long-term care remain valid for the full treatment duration or one year (whichever is longer), and prohibits renewal more frequently than once every five years for treatments lasting over a year. It also prevents health plans from restricting coverage for previously approved medications within 90 days of switching plans, unless the patient's condition changes, and mandates 90 days' notice before any coverage restriction. The bill directly affects patients with chronic conditions and health insurance carriers in Maine.
LD 1123 provides ongoing state funding to establish two Public Service Coordinator positions within the Maine Department of Education. These coordinators will directly assist public school districts in navigating MaineCare (Maine's Medicaid program) reimbursement processes for student health services. The bill allocates $204,172 for the 2025-26 fiscal year and $283,836 for 2026-27 to cover salaries and operational costs for these roles. The key mechanism is creating dedicated staff to provide technical assistance, streamline billing, and improve schools' ability to receive reimbursements for covered health services. This affects all public school districts in Maine that seek MaineCare reimbursement for student health-related services.
This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.
This bill requires Maine's Department of Health and Human Services to apply for federal approval by December 31, 2025, to establish continuous health insurance coverage for children under 6 years old enrolled in Medicaid or the Children's Health Insurance Program (CHIP). Once approved, these children would maintain coverage until their 6th birthday, regardless of changes in their family's income. Coverage could end only if the child moves out of state, a parent requests termination, the child dies, or eligibility was mistakenly granted due to fraud or error.
This bill requires the Maine Department of Health and Human Services to provide free water testing for arsenic and PFAS (perfluoroalkyl substances) to low-income rural households using private wells. It expands existing testing programs by adding PFAS testing through state-approved labs, funded by the department's dedicated testing account, with no fees charged to eligible residents. The bill also mandates educational outreach to inform low-income well owners about the free testing and eligibility for state grants to install water treatment systems if contaminants exceed state standards. These provisions directly affect rural low-income residents relying on private wells, aiming to improve access to safe drinking water through expanded testing and treatment support.
LD 703 establishes a Maine Health Care Gap Year Program that allocates $500,000 from the General Fund for the 2025-26 fiscal year to incentivize recent college graduates to work in critical health care positions. The program specifically targets underserved and rural communities to address workforce shortages in these areas. It directly affects recent graduates who participate and health care facilities in regions with limited access to services. The initiative provides a structured one-time opportunity for new graduates to gain experience while supporting community health needs.
This bill requires health insurance plans in Maine to cover blood testing for perfluoroalkyl and polyfluoroalkyl substances (PFAS) when a healthcare provider deems it medically necessary based on guidelines from the National Academies of Sciences, Engineering, and Medicine. It prohibits insurers from charging deductibles, copays, or coinsurance for these tests. The requirement applies to all health insurance plans issued or renewed in Maine on or after January 1, 2026. The bill states this coverage does not expand the state's essential health benefits under federal law, as it aligns with existing coverage for outpatient lab services.
LD 1738 establishes a grant program to fund community efforts in safely disposing of used hypodermic needles (biohazard waste), directly supporting community organizations (like needle exchange programs) and local health departments. The program provides funding for purchasing disposal containers, hiring staff to collect discarded needles, and running public education campaigns. Grants prioritize projects in areas with rising reports of improperly discarded needles and those using collaborative or innovative approaches. The Maine Center for Disease Control and Prevention will administer the program and submit annual reports to the legislature on outcomes and funding needs.
LD 858 creates a state grant program to help schools access behavioral and mental health services for students. It provides schools with $3,000 to $9,000 annually based on student population (e.g., $9,000 for schools over 500 students) to contract with licensed external providers. The grants cannot cover services already paid for by MaineCare, and funds must supplement - not replace - existing school mental health staff. This program, funded at $1.353 million yearly starting in 2025-26, directly supports school districts in expanding student mental health resources.
LD 163 requires all health insurance plans in Maine covering prescription drugs or outpatient services to fully cover federally approved nonprescription oral hormonal contraceptives and emergency contraceptives without any deductibles, copays, or coinsurance. This applies directly to health insurers and enrollees, eliminating out-of-pocket costs for these specific contraceptives. The bill clarifies that no prescription is needed to obtain these items, and coverage must include supplies for a full 12-month period. It specifically excludes coverage for abortion-inducing drugs. The law updates Maine’s health insurance coverage requirements to align with federal contraceptive approvals.
